Surgery following neoadjuvant therapy is safe and offers improved long-term prognosis

G. Massard (Strasbourg, France)

Source: Annual Congress 2007 - Controversies in surgical oncology
Session: Controversies in surgical oncology
Session type: Symposium
Number: 3984

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Massard (Strasbourg, France). Surgery following neoadjuvant therapy is safe and offers improved long-term prognosis. Annual Congress 2007 - Controversies in surgical oncology

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of neoadjuvant therapies on surgical indications and early postoperative outcome
Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts
Year: 2005

ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
Source: Eur Respir J 2009; 34: 17-41
Year: 2009



Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumour
Source: Eur Respir J 2007; 29: 117-126
Year: 2007



Improved overall survival after early recurrence of lung cancer following the introduction of CT-based follow-up for patients initially treated with curative intent by (chemo)radiotherapy (CRT).
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017


What outcome after the prescription of neoadjuvant chemotherapy in lung cancer?
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011


Early stage nonsmall-cell lung cancer: therapeutic options (surgery, adjuvant and neoadjuvant therapy)
Source: Annual Congress 2011 - PG10 Management of thoracic tumours in practice: a HERMES basic course
Year: 2011


ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
Source: Guideline 2009
Year: 2009


Postoperative lung cancer relapse after chemoradiation therapy
Source: International Congress 2014 – Thoracic oncology grand round - an interactive session
Year: 2014



Neoadjuvant chemotherapy for NSCLC, lung function and surgical therapy – which is their connection?
Source: International Congress 2019 – Lung function testing: from experimental investigations to clinical applications
Year: 2019


Locally advanced disease – indications and results of extended resections
Source: Annual Congress 2005 - Borderline indications for surgical treatment of non-small cell lung cancer
Year: 2005

Preoperative endobronchial photodynamic therapy improves surgical radicalism for locally advanced NSCLC
Source: Annual Congress 2012 - From the laser through the stent to the valve: the broad spectrum of interventional pneumology
Year: 2012

The effect of a prehabilitation program on cardiorespiratory capacity following neoadjuvant treatment prior to surgery for locally advanced esophagogastric cancer
Source: International Congress 2017 – Best abstracts in the management of chronic respiratory diseases
Year: 2017

Combined and organ-saving operations in patients with advanced lung cancer after induction chemotherapy
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010

Improved overall survival after late recurrence of lung cancer following the introduction of CT-based follow-up for patients treated with curative intent
Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies
Year: 2018



SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection
Source: Eur Respir J, 56 (5) 2000118; 10.1183/13993003.00118-2020
Year: 2020



The effect of resection surgery on long-term treatment outcomes of patients with MDR/XDR-TB
Source: International Congress 2017 – Treatment of multi-drug-resistant tuberculosis (MDRTB): where are we now?
Year: 2017